Hi guys,
In lieu of any new information, I just wanted to run some ideas by everyone with regard to commercialization.
I think hellouser's conversation about an extra 2-3 years of FDA oversight might be true, unfortunately.
On LinkedIn, the Director for Regulatory Affairs has the following statement on his profile regarding his work with Aderans:
"Leading a team of junior Regulatory and Clinical Affairs staff to beat 7 years of timelines and challenges while embracing startup mentality and creativity to gain back time and dollars to get to market."
He was hired in March of 2011, 8 months after Aderans speculated on a 2014 commercialization date. Perhaps within that 8 months they encountered FDA complications and hired this guy to help out? The 7 years statement seems a bit ominous and I'm not really sure what to make of it...
In lieu of any new information, I just wanted to run some ideas by everyone with regard to commercialization.
I think hellouser's conversation about an extra 2-3 years of FDA oversight might be true, unfortunately.
On LinkedIn, the Director for Regulatory Affairs has the following statement on his profile regarding his work with Aderans:
"Leading a team of junior Regulatory and Clinical Affairs staff to beat 7 years of timelines and challenges while embracing startup mentality and creativity to gain back time and dollars to get to market."
He was hired in March of 2011, 8 months after Aderans speculated on a 2014 commercialization date. Perhaps within that 8 months they encountered FDA complications and hired this guy to help out? The 7 years statement seems a bit ominous and I'm not really sure what to make of it...
Comment